Isentress Hd Generic Name & Formulations
Legal Class
Rx
General Description
Raltegravir (as potassium) 600mg; film-coated tabs.
Pharmacological Class
HIV-1 integrase strand transfer inhibitor (INSTI).
See Also
How Supplied
Chew tabs, film-coated tabs—60; Susp (pkts)—1, 60 (w. syringes, mixing cups)
Manufacturer
Isentress Hd Indications
Indications
HIV-1 infection, in combination with other antiretrovirals.
Isentress Hd Dosage and Administration
Adult
Film-coated tabs: swallow whole.Treatment-naïve or virologically suppressed on Isentress 400mg twice daily: 1200mg (2 x 600mg) once daily or 400mg twice daily. Treatment-experienced: 400mg twice daily. Avoid dosing before dialysis sessions. Concomitant rifampin: 800mg (2 x 400mg) twice daily.
Children
<4 weeks: use oral susp. Film-coated tabs: swallow whole. ≥4 weeks (<25kg): use other forms; (≥25kg): 400mg twice daily; (≥40kg): treatment-naïve or virologically suppressed on Isentress 400mg twice daily: 1200mg (2 x 600mg) once daily or 400mg twice daily. If unable to swallow, can use chew tabs: (3–<6kg): 25mg twice daily; (6–<10kg): 50mg twice daily; (10–<14kg): 75mg twice daily; (14–<20kg): 100mg twice daily; (20–<25kg): 150mg twice daily; (25–<28kg): 150mg twice daily; (28–<40kg): 200mg twice daily; ≥40kg: 300mg twice daily. Chew tabs max dose: 300mg twice daily. The 25mg chew tabs may be crushed for those who have difficulty chewing. See full labeling.
Isentress Hd Contraindications
Not Applicable
Isentress Hd Boxed Warnings
Not Applicable
Isentress Hd Warnings/Precautions
Warnings/Precautions
Chew tabs or oral susp are not interchangeable with the film-coated tabs. Monitor liver aminotransferases, myopathy, and rhabdomyolysis. Discontinue if signs/symptoms of severe skin or hypersensitivity reactions develop. Hepatic impairment: Isentress HD not recommended. Pregnancy. Nursing mothers: not recommended.
Isentress Hd Pharmacokinetics
See Literature
Isentress Hd Interactions
Interactions
May be antagonized by UGT1A1 inducers (eg, rifampin; see Adult dose) and potentiated by UGT1A1 inhibitors. Concomitant aluminum and/or magnesium-containing antacids, other strong enzyme inducers (eg, carbamazepine, phenobarbital, phenytoin): not recommended. Caution with concomitant drugs known to cause myopathy or rhabdomyolysis (eg, statins). Isentress HD: concomitant calcium carbonate antacid, rifampin, tipranavir/ritonavir, etravirine: not recommended.
Isentress Hd Adverse Reactions
Adverse Reactions
Insomnia, headache, dizziness, nausea, fatigue, creatinine kinase elevations, myopathy, rhabdomyolysis; severe skin reactions (eg, Stevens-Johnson syndrome, toxic epidermal necrolysis), hypersensitivity, immune reconstitution syndrome.
Isentress Hd Clinical Trials
See Literature
Isentress Hd Note
Notes
Register pregnant patients exposed to raltegravir by calling (800) 258-4263.
Isentress Hd Patient Counseling
See Literature
Images
